Skip to main content

Table 2 Effect of Matrine salvianolic acid B salt on AST and ALT in rats

From: Hepatoprotective effect of Matrine salvianolic acid B salt on Carbon Tetrachloride-Induced Hepatic Fibrosis

Treatment

Doses (mg/kg)

AST (U/L)

ALT (U/L)

Normal control

——

45.59 ± 3.68

32.12 ± 14.09

CCl4

——

211.20 ± 42.07##

221.24 ± 42.35##

Matrine+ CCl4

50

142.87 ± 36.99**

138.87 ± 32.67**

Salvianolic acid B+ CCl4

150

104.22 ± 20.67**

154.92 ± 60.64**

Matrine salvianolic acid B Salt+ CCl4

25

159.10 ± 46.19**

169.92 ± 51.42**

50

119.80 ± 25.69**

144.33 ± 44.93**

100

102.49 ± 25.71**b

96.09 ± 27.28**ac

Fu fang bie jia ruan gan pian+ CCl4

780

110.3 ± 26.62**

117.26 ± 40.70**

  1. Data is expressed as the mean±SD (n = 12).
  2. ##p < 0.01 vs. the normal control group; **p < 0.01 vs. the CCl4-treated group;
  3. ap < 0.05, bp < 0.01 vs. the Matrine group; cp < 0.01 vs. the Salvianolic acid B group.